MX340143B - Composiciones de pared de célula de ácido ribonucléico bacterial y métodos para hacerlas y usarlas. - Google Patents

Composiciones de pared de célula de ácido ribonucléico bacterial y métodos para hacerlas y usarlas.

Info

Publication number
MX340143B
MX340143B MX2013004044A MX2013004044A MX340143B MX 340143 B MX340143 B MX 340143B MX 2013004044 A MX2013004044 A MX 2013004044A MX 2013004044 A MX2013004044 A MX 2013004044A MX 340143 B MX340143 B MX 340143B
Authority
MX
Mexico
Prior art keywords
making
methods
cell wall
ribonucleic acid
acid cell
Prior art date
Application number
MX2013004044A
Other languages
English (en)
Other versions
MX2013004044A (es
Inventor
C Phillips Nigel
C Filion Mario
Richard Holan Zdenek
Ke Danbing
Elrafih Mohamed
Velji Iqubal
Original Assignee
Telesta Therapeutics Ip Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telesta Therapeutics Ip Inc filed Critical Telesta Therapeutics Ip Inc
Publication of MX2013004044A publication Critical patent/MX2013004044A/es
Publication of MX340143B publication Critical patent/MX340143B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C12N1/066—Lysis of microorganisms by physical methods
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer

Abstract

La presente invención se refiere a composiciones micobacteriales novedosas que contienen RNA y paredes de célula, y métodos para hacer y usar estas composiciones. Estas composiciones tienen una actividad anti cáncer y estimulante inmune. La presente invención también se refiere a un medio sintético para el cultivo de microbacterias.
MX2013004044A 2010-10-13 2011-10-13 Composiciones de pared de célula de ácido ribonucléico bacterial y métodos para hacerlas y usarlas. MX340143B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39249810P 2010-10-13 2010-10-13
US39358910P 2010-10-15 2010-10-15
PCT/IB2011/054539 WO2012049654A1 (en) 2010-10-13 2011-10-13 Bacterial ribonucleic acid cell wall compositions and methods of making and using them

Publications (2)

Publication Number Publication Date
MX2013004044A MX2013004044A (es) 2013-08-15
MX340143B true MX340143B (es) 2016-06-28

Family

ID=45937957

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004044A MX340143B (es) 2010-10-13 2011-10-13 Composiciones de pared de célula de ácido ribonucléico bacterial y métodos para hacerlas y usarlas.

Country Status (19)

Country Link
US (5) US9044422B2 (es)
EP (1) EP2571979B1 (es)
JP (1) JP6163425B2 (es)
KR (2) KR20140031168A (es)
CN (2) CN103354833B (es)
AR (1) AR083443A1 (es)
AU (1) AU2011315093B2 (es)
BR (1) BR112013008727A2 (es)
CA (1) CA2799442C (es)
DK (1) DK2571979T3 (es)
ES (1) ES2829416T3 (es)
HU (1) HUE052413T2 (es)
IL (1) IL225718A (es)
MX (1) MX340143B (es)
RU (1) RU2013121577A (es)
SG (1) SG189365A1 (es)
UY (1) UY33668A (es)
WO (1) WO2012049654A1 (es)
ZA (1) ZA201302722B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX340143B (es) 2010-10-13 2016-06-28 Telesta Therapeutics Ip Inc Composiciones de pared de célula de ácido ribonucléico bacterial y métodos para hacerlas y usarlas.
US10434171B2 (en) 2016-12-23 2019-10-08 United States of America as Represented by Secretary of Agriculture Microfluidized Mycobacterium avium fragments as an adjuvant and carrier for mucosal vaccine delivery
US20200237904A1 (en) * 2017-01-26 2020-07-30 Immune Therapeutics Inc. Methods and Compositions Useful for Treating Cancer
WO2019088590A2 (ko) 2017-11-06 2019-05-09 서울대학교 산학협력단 마이코박테리움 파라고르도네의 항암 면역치료법 용도
CN111000978B (zh) * 2019-11-22 2023-03-10 中山大学附属第五医院 Tlt-2在制备治疗结核病药物中的应用
CN112156719B (zh) * 2020-08-26 2022-02-22 夏文杰 一种两性糖脂生物表面活性剂及其制备方法
CN113341023B (zh) * 2021-06-30 2022-12-23 大连医科大学附属第一医院 一种基于液质联用的血清二氨基庚二酸的检测试剂盒及检测方法与应用
CN114958831A (zh) * 2022-06-30 2022-08-30 上海纳米技术及应用国家工程研究中心有限公司 一种难裂解细菌基因组dna提取方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5328989B2 (es) * 1974-05-27 1978-08-17
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
DK0681479T3 (da) * 1993-01-29 1999-11-08 Vetrepharm Inc Immunterapeutisk præparat
DE4422859C2 (de) * 1994-06-30 2000-10-05 Laves Arzneimittel Gmbh Wäßrige Zellextrakte aus Mykobacterien
AUPO359396A0 (en) * 1996-11-13 1996-12-05 Amrad Operations Pty. Limited A method of treatment and pharmaceutical compositions useful for same
US6139844A (en) 1997-04-02 2000-10-31 Bioniche, Inc. Method for treating or eliminating a parasitic disease
EP1003525B1 (en) * 1997-08-05 2002-11-20 Bioniche Life Sciences Inc. Composition and method for regulating cell proliferation and cell death
WO1999042113A1 (en) * 1998-02-18 1999-08-26 Bioniche Life Sciences Inc. Composition and method for the treatment of bladder cancer
CA2353905C (en) * 1998-12-04 2010-06-22 Nigel C. Phillips Chemotherapeutic composition and method
DK1135164T3 (da) 1998-12-04 2004-12-20 Bioniche Life Sciences Inc Sammensætning til behandling af inflammation
US6809081B1 (en) 1998-12-04 2004-10-26 Bioniche Life Sciences, Inc. Chemotherapeutic composition and method
US6794368B1 (en) 1999-04-01 2004-09-21 Bioniche Life Sciences Inc. Composition and method for inducing apoptosis in prostate cancer cells
US6890541B1 (en) * 1999-07-23 2005-05-10 Bioniche Life Sciences, Inc. Method for enhancing production performance in an animal
JP4215429B2 (ja) 1999-12-28 2009-01-28 バイオニケ ライフ サイエンシーズ インコーポレイテッド 癌治療におけるヒアルロン酸
UA79952C2 (en) * 2001-12-10 2007-08-10 Kabulesh Mafatlal Khamar MYCOBACTERIUM w APPLICATIONS FOR CANCER TREATMENT
MX340143B (es) 2010-10-13 2016-06-28 Telesta Therapeutics Ip Inc Composiciones de pared de célula de ácido ribonucléico bacterial y métodos para hacerlas y usarlas.

Also Published As

Publication number Publication date
CN103354833A (zh) 2013-10-16
ZA201302722B (en) 2014-06-25
CA2799442C (en) 2015-07-14
KR20160083968A (ko) 2016-07-12
EP2571979A4 (en) 2013-12-11
SG189365A1 (en) 2013-05-31
CN103354833B (zh) 2016-11-16
US9220765B2 (en) 2015-12-29
US9180176B2 (en) 2015-11-10
BR112013008727A2 (pt) 2016-06-28
US20160151475A1 (en) 2016-06-02
JP6163425B2 (ja) 2017-07-12
US20130142828A1 (en) 2013-06-06
KR20140031168A (ko) 2014-03-12
MX2013004044A (es) 2013-08-15
US20140322372A1 (en) 2014-10-30
AR083443A1 (es) 2013-02-27
AU2011315093B2 (en) 2013-10-17
WO2012049654A1 (en) 2012-04-19
US9044422B2 (en) 2015-06-02
AU2011315093A8 (en) 2013-01-17
US20140170189A1 (en) 2014-06-19
DK2571979T3 (da) 2020-09-28
CN105943559A (zh) 2016-09-21
US20150224183A1 (en) 2015-08-13
IL225718A (en) 2016-04-21
CA2799442A1 (en) 2012-04-19
AU2011315093A1 (en) 2013-01-10
US9180177B2 (en) 2015-11-10
JP2014502256A (ja) 2014-01-30
HUE052413T2 (hu) 2021-04-28
RU2013121577A (ru) 2014-11-20
EP2571979A1 (en) 2013-03-27
UY33668A (es) 2012-08-31
EP2571979B1 (en) 2020-06-24
IL225718A0 (en) 2013-06-27
ES2829416T3 (es) 2021-05-31

Similar Documents

Publication Publication Date Title
MX2013004044A (es) Composiciones de pared de celula de acido ribonucleico bacterial y metodos para hacerlas y usarlas.
AU2018253607A1 (en) Novel class of glyphosate resistance genes
MX2014003212A (es) Microorganismos y metodos para producir alquenos.
WO2012112730A3 (en) Compositions and methods for delivering nucleic acid to a cell
IN2014CN03890A (es)
EP4269584A3 (en) Selective antisense compounds and uses thereof
MX348612B (es) Microorganismos y metodos para producir 2,4 - pentadienoato, butadieno, propileno, 1,3 - butanodiol y alcoholes relacionados.
MX2011008495A (es) Formulaciones de caldo de fermentacion.
MX339607B (es) Microorganismos geneticamente modificados que metabolizan xilosa.
MY156588A (en) Systems using cell culture for production of isoprene
WO2010096588A3 (en) Cell culture media containing combinations of proteins
MX2020003168A (es) Pirimidinas modificadas en la posicion 5 y su uso.
MY156938A (en) Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
MX2009009371A (es) Produccion mejorada de derivados de acidos grasos.
AR077916A1 (es) Microorganismos (travstochytrium y schizochytrium) productores de acido eicosapentenoico, composiciones de acido graso, y metodos de elaboracion y uso de los mismos
NZ627373A (en) Genes involved in noscapine production
MY171760A (en) Microorganisms and methods for the production of caprolactone
EP3030647A4 (en) Methods of producing algal cell cultures and biomass, lipid compounds and compositions, and related products
WO2012177983A3 (en) Microorganisms for producing ethylene glycol and methods related thereto
EA201201278A1 (ru) Штаммы дрожжей и их использование при производстве липидов
MX2014006570A (es) Cocteles de enzimas preparados a partir de cultivos mezclados.
WO2011160052A3 (en) Methods and compositions for sequence specific rna endonucleases
MY160740A (en) Method of producing lauric acid-containing oil or fat
MY182946A (en) Production of organic acids by fermentation at low ph
EP3666900A3 (en) Cell-based production of nonulosonates

Legal Events

Date Code Title Description
HC Change of company name or juridical status

Owner name: NOKIA TECHNOLOGIES OY

FG Grant or registration